Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Oct;18(9):655-666.
doi: 10.1111/hiv.12505. Epub 2017 Apr 24.

A tale of two countries: all-cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

Collaborators, Affiliations
Comparative Study

A tale of two countries: all-cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

S Patterson et al. HIV Med. 2017 Oct.

Abstract

Objectives: We sought to compare all-cause mortality of people living with HIV and accessing care in Canada and the UK.

Methods: Individuals from the Canadian Observational Cohort (CANOC) collaboration and UK Collaborative HIV Cohort (UK CHIC) study who were aged ≥ 18 years, had initiated antiretroviral therapy (ART) for the first time between 2000 and 2012 and who had acquired HIV through sexual transmission were included in the analysis. Cox regression was used to investigate the difference in mortality risk between the two cohort collaborations, accounting for loss to follow-up as a competing risk.

Results: A total of 19 960 participants were included in the analysis (CANOC, 4137; UK CHIC, 15 823). CANOC participants were more likely to be older [median age 39 years (interquartile range (IQR): 33, 46 years) vs. 36 years (IQR: 31, 43 years) for UK CHIC participants], to be male (86 vs. 73%, respectively), and to report men who have sex with men (MSM) sexual transmission risk (72 vs. 56%, respectively) (all P < 0.001). Overall, 762 deaths occurred during 98 798 person-years (PY) of follow-up, giving a crude mortality rate of 7.7 per 1000 PY [95% confidence interval (CI): 7.1, 8.3 per 1000 PY]. The crude mortality rates were 8.6 (95% CI: 7.4, 10.0) and 7.5 (95% CI: 6.9, 8.1) per 1000 PY among CANOC and UK CHIC study participants, respectively. No statistically significant difference in mortality risk was observed between the cohort collaborations in Cox regression accounting for loss to follow-up as a competing risk (adjusted hazard ratio 0.86; 95% CI: 0.72-1.03).

Conclusions: Despite differences in national HIV care provision and treatment guidelines, mortality risk did not differ between CANOC and UK CHIC study participants who acquired HIV through sexual transmission.

Keywords: AIDS; HIV; UK; Canada; antiretroviral therapy; mortality.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan−Meier plot showing time to death stratified by cohort collaboration (n = 19 960). ART, antiretroviral therapy; CANOC, Canadian Observational Cohort; UK CHIC, UK Collaborative HIV Cohort.

References

    1. Public Health England . HIV in the United Kingdom: 2014 Report 2014. Available at https://http://www.gov.uk/government/uploads/system/uploads/attachment_d... (accessed 10 December 2015).
    1. Williams I, Churchill D, Anderson J et al British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012. HIV Med 2014; 15 (Suppl 1): 1–85. - PubMed
    1. BHIVA . Standards of Care for People Living with HIV, 2013 2012. Available at http://www.bhiva.org/documents/Standards-of-care/BHIVAStandardsA4.pdf (accessed 21 September 2015).
    1. Public Health Agency of Canada . Estimates of HIV Incidence, Prevalence and Proportion Undiagnosed in Canada, 2014. 2015. Available at http://healthycanadians.gc.ca/publications/diseases-conditions-maladies-... (accessed 20 April 2016).
    1. Baril J, Rouleau D, Fortin C et al La Therapie Antiretrovirale Pour Les Adultes Infectes Par Le VIH. 2015. Available at http://publications.msss.gouv.qc.ca/acrobat/f/documentation/2014/14-337-... (accessed 10 December 2015).

Publication types

Substances

LinkOut - more resources